|
IMI
INTERNATIONAL MEDICAL INNOVATIONS INC.
|
Place de cotation: TORONTO (IMI)
Amex:IME
IMI is a world leader in
predictive medicine, dedicated to developing rapid, non-invasive tests
for the early detection of life-threatening diseases, particularly cardiovascular
disease and cancer. The company’s head office is located in Toronto, and
its research and product development facility is at McMaster University
in Hamilton, Ontario.
4211
Yonge Street, Suite 300, Toronto, Ontario, Canada M2P 2A9
Tel:
(416) 222-3449 Fax: (416) 222-4533
|
